시장보고서
상품코드
1309221

치료제 모니터링 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측(2018-2028년)

Therapeutic Drug Monitoring Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product, By Technology, By Class of Drug, By End User, By Region, and Competition

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 113 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 치료제 모니터링 시장은 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다. 세계 헬스케어 산업의 확장은 치료제 모니터링에 대한 수요를 가속화하고 있습니다. 치료제 모니터링은 혈류에 있는 여러 약물을 측정하여 투여된 약물의 정확한 용량을 확인하는 검사입니다. 이는 일반적으로 치료 지수가 좁은, 즉 치료량과 독성량의 차이가 상대적으로 작은 특정 약물의 안전성과 효능을 최적화하기 위해 수행됩니다. 항부정맥제, 항생제, 항간질제, 향정신성 약물은 모두 효과와 안전성을 보장하기 위해 모니터링이 필요합니다. 치료제 모니터링의 목적은 부작용의 위험을 최소화하면서 환자가 원하는 치료 효과를 얻기 위해 적절한 양의 약물을 투여하고 있는지 확인하는 것입니다. 특정 간격으로 혈중 약물 농도를 측정하고 약물 농도를 목표 범위 내로 유지하기 위해 필요한 경우 투약량을 조정하는 것을 포함합니다. 정확한 투약량과 약물의 치료 효과에 대한 사람들의 인식이 높아짐에 따라 다양한 약물의 부작용 및 환자 건강에 대한 부정적인 영향의 발생률이 증가함에 따라 향후 몇 년 동안 세계 치료제 모니터링 시장의 성장에 유리한 기회를 창출할 것으로 예상됩니다.

임상시험에 따른 R&D 성장

치료제 모니터링(TDM) 관련 R&D 프로젝트에 대한 관심이 높아지고 다양한 치료 분야에서 약물 모니터링 검사가 널리 사용되고 있는 것도 시장 성장에 영향을 미치고 있습니다. 암, 신경질환, HIV, 자가면역질환, 심장질환 등의 발병률 증가와 더불어 다양한 적응증에서 기술 사용을 확대하기 위한 연구개발 노력과 임상연구의 증가가 세계 치료제 모니터링 시장의 성장을 뒷받침하고 있습니다. Journal of Clinical Neurology는 2021년 8월, 전 세계 7,000만 명 이상이 앓고 있는 간질은 치매, 뇌졸중에 이어 세 번째로 발병률이 높은 신경질환이라고 보고했습니다. WHO의 추산에 따르면 2021년 현재 전 세계 5,500만 명 이상이 치매를 앓고 있다고 보고했습니다. 매년 1,000만 명에 가까운 새로운 사례가 보고되고 있습니다. 치매 중 가장 흔한 알츠하이머형 치매는 60-70%에 해당할 수 있습니다. 따라서 예측 기간 동안 이러한 질환의 위험 증가는 치료제 모니터링 시장의 성장을 촉진할 것으로 예상됩니다.

장기 이식에서 치료 모니터링의 사용

고형 장기 이식 환자를 관리하기 위해서는 면역억제제 치료제 모니터링을 실시해야 합니다. 면역억제제는 신체의 장기 거부반응을 예방하기 위해 이식 환자에게 투여됩니다. 임상의는 부작용의 가능성과 치료 효과의 이상적인 균형을 맞추기 위해 각 환자에게 투여하는 면역억제제를 조정해야 합니다. 환자의 약력학 및 약동학이 다양하기 때문에 면역억제제 치료의 모니터링으로 이 목표를 달성하기 어려울 수 있습니다.

정밀 투여

정밀 약물 투여는 최근 몇 년 동안 점점 더 많은 관심을 받고 있으며, 치료제 모니터링은 이 접근법에서 중요한 역할을 할 것으로 예상됩니다. 정밀 투약은 유전, 나이, 체중, 장기 기능, 병용약물 등 환자별 특성에 따라 개별 환자에게 맞는 약물 용량을 조정하는 것을 포함합니다. 치료제 모니터링은 개별화된 치료 결과를 달성하기 위해 약물 투여를 최적화하는 데 도움이 되며, 따라서 치료제 모니터링 실무에서 정밀 투약 접근법을 더 많이 채택하게 될 것입니다. 이는 예측 기간 동안 세계 치료제 모니터링 시장의 성장에 새로운 전망을 제시할 것입니다.

헬스케어 IT 산업의 번영

첨단 기술의 사용 증가와 헬스케어에 IT의 통합은 헬스케어 산업에 혁명을 일으켰습니다. 헬스케어 분야에서 인공지능(AI)과 데이터 분석의 활용이 증가하고 있으며, 치료제 모니터링도 예외는 아닙니다. AI 알고리즘과 데이터 분석 기술은 약물 농도 데이터, 환자 특성 및 임상 결과의 대규모 데이터 세트를 분석하여 패턴과 추세를 식별하고, 투여 전략을 최적화하고 치료제 모니터링 관행을 개선하여 세계 치료제 모니터링 시장 성장에 유리한 기회를 창출할 수 있습니다.

디지털 건강 기술과 원격 의료가 최근 몇 년 동안 급속도로 발전하고 있으며, 치료제 모니터링도 이러한 플랫폼에 통합되고 있습니다. 스마트폰 앱이나 웨어러블 기기와 같은 디지털 건강 도구는 약물 농도를 원격으로 모니터링할 수 있어 보다 편리하고 접근하기 쉬운 치료제 모니터링 서비스를 가능하게 합니다. 원격 의료는 또한 특히 의료 접근성이 제한된 농촌 및 외딴 지역에서 치료제 모니터링 결과를 기반으로 한 원격 진료 및 용량 조정을 용이하게 하여 세계 치료제 모니터링 시장의 성장을 뒷받침하고 있습니다.

사용 가능한 커스터마이징

TechSci Research는 주어진 시장 데이터를 사용하여 기업의 특정 요구에 따라 맞춤형을 제공합니다. 보고서에서 다음과 같은 커스터마이징이 가능합니다.

회사 소개

  • 추가 시장 참여자(최대 5개사)에 대한 상세한 분석 및 프로파일링

목차

제1장 개요

  • 시장의 정의
  • 시장 범위
    • 대상 시장
    • 조사 대상 연도
    • 주요 시장 세분화

제2장 조사 방법

  • 조사 목적
  • 베이스라인 조사 방법
  • 주요 산업 파트너
  • 주요 협회와 2차 정보 출처
  • 예측 방법
  • 데이터 삼각측량과 검증
  • 가정과 한계

제3장 주요 요약

  • 시장 개요
  • 주요 시장 세분화 개요
  • 주요 시장 기업 개요
  • 주요 지역/국가 개요
  • 시장 성장 촉진요인, 과제, 동향 개요

제4장 고객의 소리

제5장 치료제 모니터링 세계 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 약물 클래스별
    • 최종사용자별
    • 지역별
    • 기업별(2022)
  • 제품 맵
    • 제품별
    • 기술별
    • 약제 클래스별
    • 최종사용자별
    • 지역별

제6장 북미의 치료제 모니터링 시장 전망

  • 시장 규모 및 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 약물 클래스별
    • 최종사용자별
    • 국가별
  • 북미 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 치료제 모니터링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 약물 클래스별
    • 최종사용자별
    • 국가별
  • 유럽 국가별 분석
    • 프랑스
    • 영국
    • 이탈리아
    • 독일
    • 스페인

제8장 아시아태평양의 치료제 모니터링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 약물 클래스별
    • 최종사용자별
    • 국가별
  • 아시아태평양 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 치료제 모니터링 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 약물 클래스별
    • 최종사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 치료제 모니터링 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 약물 클래스별
    • 최종사용자별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카공화국
    • 아랍에미리트
    • 사우디아라비아
    • 터키
    • 이집트

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 제품 출시
  • 인수합병
  • 기술 진보

제13장 세계의 치료제 모니터링 시장 SWOT 분석

제14장 경쟁 상황

  • Roche AG
    • Business Overview
    • Product Offerings
    • Recent Developments
    • Financials(In Case of Listed Companies)
    • Key Personnel
    • SWOT Analysis
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • bioMerieux, Inc.
  • Alere, Inc.

제15장 전략적 제안

ksm 23.08.21

Global Therapeutic Drug Monitoring Market is projected to witness impressive growth during the forecast period. The worldwide healthcare industry's expansion is accelerating the demand for therapeutic medication monitoring. Therapeutic drug monitoring is a test that measures several medications in the bloodstream to verify the correct dosage of medication being given. This is typically done to optimize the safety and effectiveness of certain medications that have a narrow therapeutic index, meaning that the difference between a therapeutic dose and a toxic dose is relatively small. Anti-arrhythmic, antibiotic, anti-epileptic, and psychotropic medications all require monitoring to guarantee their effectiveness and safety. The goal of therapeutic drug monitoring is to ensure that a patient is receiving the right dose of medication to achieve the desired therapeutic effect while minimizing the risk of adverse effects. It involves measuring drug concentrations in the blood at specific intervals and adjusting the medication dosage as needed to maintain drug levels within the target range. The growing awareness among the population pertaining to accurate dosage, and therapeutic effects of drugs coupled with increased incidences of side-effects and adverse impacts on patient health due to different medications is expected to create lucrative opportunities for the growth of global therapeutic drug monitoring market in the next few years.

The rise in demand for hospitals and medical care institutions across the globe acts as one of the major factors driving the growth of therapeutic drug monitoring market. The growing inclination for precision medicine and the significance of therapeutic drug monitoring (TDM) in organ transplant procedures both speed up market expansion. The therapeutic drug monitoring market is also positively impacted by changes in the medical sector, rising awareness, technical advancements, and a surge in pharmaceutical company investment. Additionally, the market players would benefit from increased use in the treatment of autoimmune illnesses during the projected period 2024 to 2028.

Additionally, the growing use of therapeutic drug monitoring across biologics industry and in point of care testing is further expected to support the global therapeutic drug monitoring market growth in the next few years. Biologic drugs, which are large complex molecules used to treat various conditions such as cancer, autoimmune diseases, and inflammatory disorders, are becoming increasingly important in clinical practice. Therapeutic Drug Monitoring for biologics, such as monoclonal antibodies, may involve measuring drug concentrations and anti-drug antibody levels to optimize dosing, assess treatment response, and manage immunogenicity. Similarly, Point-of-care testing (POCT), which involves performing diagnostic tests near the patient rather than sending samples to a central laboratory, is gaining popularity in clinical practice. POCT for Therapeutic Drug Monitoring may allow for more rapid and convenient monitoring of drug concentrations, enabling quicker dose adjustments and improving patient care, especially in critical care settings or resource-limited environments.

Growing Research and Development Along with Clinical Trials

The market is also influenced by the increased attention being paid to research and development projects relating to therapeutic drug monitoring (TDM) and the widespread use of the drug monitoring test in different therapeutic sectors. Increasing R&D efforts and clinical studies to broaden the use of technology in diverse indications, as well as rising rates of cancer, neurological disorders, HIV, autoimmune, and cardiac ailments, are supporting the growth of global therapeutic drug monitoring market. The Journal of Clinical Neurology reported in August 2021 that epilepsy, which affects over 70 million people globally, is the third most prevalent neurological condition after dementia and stroke. More than 55 million people are living with dementia worldwide as of 2021, estimates the WHO. Every year, there would be close to 10 million new cases reported. The most prevalent form of dementia, Alzheimer's disease, may be a factor in 60-70% of cases. Therefore, it is predicted that over the course of the projection period, rising risks of these diseases is anticipated to fuel Therapeutic Drug Monitoring market expansion.

Use of Therapeutic Monitoring in Organ Transplant

Managing patients receiving solid-organ transplants requires conducting therapeutic drug monitoring for immunosuppressive medicines. Immunosuppressants are given to transplant recipients in order to prevent organ rejection by the body. Clinicians must tailor the immunosuppressant medication they give to each patient in order to strike the ideal balance between the likelihood of side effects and the efficacy of treatment. It can be tough to accomplish this goal with immunosuppressant therapy monitoring since patients have varied pharmacodynamics and pharmacokinetics.

Precision Dosing

Precision medicine has gained increasing attention in recent years, and Therapeutic Drug Monitoring is expected to play a significant role in this approach. Precision dosing involves tailoring drug dosages to individual patients based on their specific characteristics, such as genetics, age, weight, organ function, and concomitant medications. Therapeutic Drug Monitoring can help optimize drug dosing to achieve personalized therapeutic outcomes, and hence lead to more adoption of precision dosing approaches in Therapeutic Drug Monitoring practice. This, in turn, will open new prospects for the growth of global therapeutic drug monitoring market in the forecast period.

Flourishing Healthcare IT Industry

The increasing use of advanced technologies and integration of IT into healthcare has revolutionized the healthcare industry. The use of artificial intelligence (AI) and data analytics in healthcare is on the rise, and Therapeutic Drug Monitoring is no exception. AI algorithms and data analytics techniques can be used to analyze large datasets of drug concentration data, patient characteristics, and clinical outcomes to identify patterns and trends, optimize dosing strategies, and improve Therapeutic Drug Monitoring practices, thereby creating lucrative opportunities for the growth of global therapeutic drug monitoring market.

Digital health technologies and telemedicine have gained momentum in recent years, and Therapeutic Drug Monitoring is also being integrated into these platforms. Digital health tools, such as smartphone apps or wearable devices, can enable remote monitoring of drug concentrations, allowing for more convenient and accessible Therapeutic Drug Monitoring services. Telemedicine can also facilitate remote consultations and dose adjustments based on Therapeutic Drug Monitoring results, particularly in rural or remote areas where access to healthcare may be limited, hence, supporting the growth of global therapeutic drug monitoring market.

Market Segmentation

Global Therapeutic Drug Monitoring Market is segmented based on product, technology, class of drug, end user, and region. By product, global therapeutic drug monitoring market can be segmented into consumables, equipment, immunoassay analyzers, chromatography & MS detectors, and clinical chemistry analyzers. By technology, global therapeutic drug monitoring market can be categorized into immunoassays and chromatography-mass spectrometry. Immunoassays can be further sub-segmented into Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, and Others. Chromatography-Mass Spectrometry can be split into LC-MS and GC-MS. By Class of Drug, global therapeutic drug monitoring market can be fragmented into Antiepileptic Drugs, Antibiotic Drug, Immunosuppressant Drugs, Antiarrhythmic Drug, Bronchodilator Drugs, Psychoactive Drugs, and Others. In terms of end users, global therapeutic drug monitoring market can be divided into Hospital Labs, Commercial & Private Lab, and Others. Regionally, global therapeutic drug monitoring market can be categorized into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Recent Developments

  • In January 2021, Theradiag announced that it had received CE marking for four new i-Tracker test kits for biotherapy monitoring.
  • In November 2021, Boditech Med unveiled their brand-new all-in-one cartridge system and automated immunoassay analyzer with a blood collection tube at the MEDICA 2021 trade fair.
  • The Wyoming Board of Pharmacy and Bamboo Health, formerly Appriss Health and PatientPing, announced a partnership on June 29 in May 2022, to create a solution for the Wyoming Prescription Drug Monitoring Program (PDMP).
  • In January 2022, Seer launched a next-generation proteomics research platform that can be used for categorizing the tens of thousands of proteins within the human body that drive the biological functions of both life and disease.
  • In March 2022, Biognosys launched its expanded suite of proteomics platforms which provides its customers with deep biological insights across the entire R&D pipeline, from early-stage discovery to clinical settings.

Market players

Roche AG, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux, Inc., Alere, Inc, among others, are some of the key players operating in the global therapeutic drug monitoring market.

Report Scope:

In this report, the Global Therapeutic Drug Monitoring Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Therapeutic Drug Monitoring Market, By Product:

  • Consumables
  • Equipment
  • Immunoassay Analyzers
  • Chromatography & MS Detector
  • Clinical Chemistry Analyzers

Global Therapeutic Drug Monitoring Market, By Technology:

  • Immunoassay
    • Chemiluminescence Immunoassay
    • Colorimetric Immunoassay
    • Fluorescence
    • Immunoassay
    • Radioimmunoassay
    • Others
  • Chromatography-Mass Spectrometry
    • LC-MS
    • GC-MS

Global Therapeutic Drug Monitoring Market, By Class of Drug:

  • Antiepileptic Drug
  • Antibiotic Drug
  • Immunosuppressant Drug
  • Antiarrhythmic Drug
  • Bronchodilator Drug
  • Psychoactive Drug
  • Others

Global Therapeutic Drug Monitoring Market, By Class of Drug:

  • Hospital Labs
  • Commercial & Private Labs
  • Others

Global Therapeutic Drug Monitoring Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • South Arabia
    • Saudi Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Drug Monitoring Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Therapeutic Drug Monitoring Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 5.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 5.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 5.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 5.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 5.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Product
    • 5.3.2. By Technology
    • 5.3.3. By Class of Drug
    • 5.3.4. By End User
    • 5.3.5. By Region

6. North America Therapeutic Drug Monitoring Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 6.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 6.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 6.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 6.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 6.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Therapeutic Drug Monitoring Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Class of Drug
        • 6.3.1.2.4. By End- User
    • 6.3.2. Canada Therapeutic Drug Monitoring Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Class of Drug
        • 6.3.2.2.4. By End- User
    • 6.3.3. Mexico Therapeutic Drug Monitoring Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Class of Drug
        • 6.3.3.2.4. By End- User

7. Europe Therapeutic Drug Monitoring Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 7.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 7.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 7.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 7.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 7.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Therapeutic Drug Monitoring Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Class of Drug
        • 7.3.1.2.4. By End- User
    • 7.3.2. United Kingdom Therapeutic Drug Monitoring Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Class of Drug
        • 7.3.2.2.4. By End- User
    • 7.3.3. Italy Therapeutic Drug Monitoring Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Class of Drug
        • 7.3.3.2.4. By End- User
    • 7.3.4. Germany Therapeutic Drug Monitoring Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Class of Drug
        • 7.3.4.2.4. By End- User
    • 7.3.5. Spain Therapeutic Drug Monitoring Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Class of Drug
        • 7.3.5.2.4. By End- User

8. Asia-Pacific Therapeutic Drug Monitoring Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 8.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 8.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 8.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 8.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 8.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Therapeutic Drug Monitoring Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Class of Drug
        • 8.3.1.2.4. By End- User
    • 8.3.2. India Therapeutic Drug Monitoring Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Class of Drug
        • 8.3.2.2.4. By End- User
    • 8.3.3. Japan Therapeutic Drug Monitoring Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Class of Drug
        • 8.3.3.2.4. By End- User
    • 8.3.4. South Korea Therapeutic Drug Monitoring Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Class of Drug
        • 8.3.4.2.4. By End- User
    • 8.3.5. Australia Therapeutic Drug Monitoring Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Class of Drug
        • 8.3.5.2.4. By End- User

9. South America Therapeutic Drug Monitoring Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 9.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 9.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 9.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 9.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 9.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Therapeutic Drug Monitoring Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Class of Drug
        • 9.3.1.2.4. By End- User
    • 9.3.2. Argentina Therapeutic Drug Monitoring Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Class of Drug
        • 9.3.2.2.4. By End- User
    • 9.3.3. Colombia Therapeutic Drug Monitoring Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Class of Drug
        • 9.3.3.2.4. By End- User

10. Middle East and Africa Therapeutic Drug Monitoring Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 10.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 10.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 10.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 10.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 10.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Therapeutic Drug Monitoring Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Class of Drug
        • 10.3.1.2.4. By End- User
    • 10.3.2. UAE Therapeutic Drug Monitoring Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Class of Drug
        • 10.3.2.2.4. By End- User
    • 10.3.3. Saudi Arabia Therapeutic Drug Monitoring Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Class of Drug
        • 10.3.3.2.4. By End- User
    • 10.3.4. Turkey Therapeutic Drug Monitoring Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Technology
        • 10.3.4.2.3. By Class of Drug
        • 10.3.4.2.4. By End- User
    • 10.3.5. Egypt Therapeutic Drug Monitoring Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product
        • 10.3.5.2.2. By Technology
        • 10.3.5.2.3. By Class of Drug
        • 10.3.5.2.4. By End- User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Global Therapeutic Drug Monitoring Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Roche AG
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (In Case of Listed Companies)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Siemens Healthcare GmbH
  • 14.3. Thermo Fisher Scientific, Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Beckman Coulter, Inc.
  • 14.6. Abbott Laboratories, Inc.
  • 14.7. Agilent Technologies, Inc.
  • 14.8. bioMerieux, Inc.
  • 14.9. Alere, Inc.

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제